Latest Blogs

Aug 15, 2019
Dr. Gil Morgan joins me in a conversation about how our perspectives have been enriched by work, parenthood, and online connections.
Aug 12, 2019
Over 400 attendees and exceptional international faculty members made the 2019 Best of ASCO Lebanon meeting a great success.
Aug 12, 2019
After a breast cancer diagnosis, cancer researcher Dr. Priscila Gonçalves went from "helper" to "helped." She discovered incredible kindness along the way.  
Aug 09, 2019
Planning for our first global meeting, ASCO Breakthrough: A Global Summit for Oncology Innovators, is almost complete.
Subscribe to this column

International Perspectives

International Perspectives provides an interactive platform for international leaders in their respective fields to share perspectives on oncology topics. International Perspectives contributors are invited to post by invitation from ASCO’s volunteer leadership and key staff.

Feb 02, 2015
By Monica Malik MD, DNB. It is estimated that almost 50% of all cancers are related to unhealthy choices like tobacco, alcohol, physical inactivity, unhealthy eating habits, unsafe sex and other modifiable environmental factors. Obesity is already on its way to overtake tobacco as the leading cause...
Feb 02, 2015
By Ian N. Olver, MD, PhD, FRACP. One-third of cancer deaths could be prevented by lifestyle choices alone. If there was a drug that claimed that success, it would be front page news. Changing behavior doesn’t seem dramatic, yet can be very difficult to achieve. The three areas in which the most...
Feb 02, 2015
By Sana Al Sukhun, MD, MSc, President of Jordan Oncology Society. Early detection has become the motto of public health campaigns all over the world. Not only does it reduce the burden of disease by reducing morbidity (complications of both disease and treatment), but also by reducing associated...
Feb 02, 2015
By Paul Ruff, MD, University of Witwatersrand, Johannesburg, South Africa. Since the turn of the century, we have seen a paradigm shift in the way we treat cancer, with the advent of targeted therapies, especially monoclonal antibodies and small molecule kinase inhibitors. Indeed the development of...
Nov 18, 2014
Tanja Cufer, MD, PhDASCO International Clinical Trials Workshop (ICTW) Working Group Chair    Dr. Tanja Cufer presents at the International Clinical Trials 

Pages